NCT01019928View on ClinicalTrials.gov

Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)

PHASE2CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Sensitivity in Esophagus

Interventions

DRUG

AZD1386

95 mg, oral solution, single dose

DRUG

Placebo to AZD1386

Placebo, oral solution, single dose

Trial Locations (2)

Unknown

Research Site, Århus C

Research Site, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY